Pediatric Surgery International

, Volume 34, Issue 7, pp 735–742 | Cite as

Response to pulmonary vasodilators in infants with congenital diaphragmatic hernia

  • Vasantha H. S. Kumar
  • Rita Dadiz
  • Jamie Koumoundouros
  • Stephanie Guilford
  • Satyan Lakshminrusimha
Original Article
  • 47 Downloads

Abstract

Background

Congenital diaphragmatic hernia (CDH) is associated with lung hypoplasia, cardiac dysfunction and pulmonary hypertension. Inhaled nitric oxide (iNO) and milrinone are commonly used pulmonary vasodilators in CDH. We studied the hemodynamic effects of iNO and milrinone in infants with CDH.

Methods

A retrospective chart review was performed of all CDH infants admitted to two regional perinatal centers and infants classified into three groups: No-iNO group; iNO-responders and iNO-nonresponders. Oxygenation and hemodynamic effects of iNO and milrinone were assessed by blood gases and echocardiography.

Results

Fifty-four percent (39/72) of infants with CDH received iNO and 31% of these infants (12/39) had complete oxygenation response to iNO. Oxygenation response to iNO was not associated with a decrease in right ventricular pressures (RVP) or ECMO use. Four infants (33%) in the iNO-responder group and eight infants (30%) in the iNO-nonresponder group received milrinone. Milrinone lowered RVP and improved ejection fraction (EF). Response to iNO was associated with improved oxygenation to milrinone and increased survival following ECMO (67 vs. 20% among nonresponders).

Conclusions

Response to inhaled nitric oxide in combination with milrinone may be associated with improved oxygenation and better survival after ECMO in infants with CDH.

Keywords

CDH Pulmonary hypertension Inhaled nitric oxide Milrinone Infants 

Notes

Acknowledgements

This research work was performed without any support from external funding or grants. No funds were received for covering the costs to publish in open access.

Author contributions

HSVK and SL conceived and designed the project; RD and SG provided help with IRB approval; RD, JK and SG substantially contributed to acquisition, analysis and interpretation of data; all the authors (VK, RD, JK, SG and SL) played a critical role in drafting and revising the manuscript for intellectual content.

Compliance with ethical standards

Conflict of interest

The authors have no conflict of interests to declare.

Ethical approval

This article does not contain any studies with animals performed by any of the authors.

Research involving human participants

This is a retrospective case–control study. The University at Buffalo Institutional Review Board of the State University of New York, Buffalo (MODCR00001406), and the Research Subjects Review Board at the University of Rochester, Rochester (RSRB0006718), approved the study protocol for data collection in study patients.

References

  1. 1.
    Barrington KJ, Finer N, Pennaforte T, Altit G (2017) Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev 1:CD000399.  https://doi.org/10.1002/14651858.CD000399.pub3 PubMedGoogle Scholar
  2. 2.
    The Neonatal Inhaled Nitric Oxide Study Group (NINOS) (1997) Inhaled nitric oxide and hypoxic respiratory failure in infants with congenital diaphragmatic hernia. Pediatrics 99(6):838–845CrossRefGoogle Scholar
  3. 3.
    Snoek KG, Capolupo I, van Rosmalen J, Hout Lde J, Vijfhuize S, Greenough A, Wijnen RM, Tibboel D, Reiss IK, Consortium CE (2016) Conventional mechanical ventilation versus high-frequency oscillatory ventilation for congenital diaphragmatic hernia: a randomized clinical trial (the VICI-trial). Ann Surg 263(5):867–874.  https://doi.org/10.1097/SLA.0000000000001533 CrossRefPubMedGoogle Scholar
  4. 4.
    Kumar VH, Swartz DD, Rashid N, Lakshminrusimha S, Ma C, Ryan RM, Morin FC 3rd (2010) Prostacyclin and milrinone by aerosolization improve pulmonary hemodynamics in newborn lambs with experimental pulmonary hypertension. J Appl Physiol 109(3):677–684.  https://doi.org/10.1152/japplphysiol.01082.2009 CrossRefPubMedGoogle Scholar
  5. 5.
    Lakshminrusimha S, Porta NF, Farrow KN, Chen B, Gugino SF, Kumar VH, Russell JA, Steinhorn RH (2009) Milrinone enhances relaxation to prostacyclin and iloprost in pulmonary arteries isolated from lambs with persistent pulmonary hypertension of the newborn. Pediatr Crit Care Med 10(1):106–112.  https://doi.org/10.1097/PCC.0b013e3181936aee CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Rashid N, Morin FC 3rd, Swartz DD, Ryan RM, Wynn KA, Wang H, Lakshminrusimha S, Kumar VH (2006) Effects of prostacyclin and milrinone on pulmonary hemodynamics in newborn lambs with persistent pulmonary hypertension induced by ductal ligation. Pediatr Res 60(5):624–629.  https://doi.org/10.1203/01.pdr.0000242343.84510.81 CrossRefPubMedGoogle Scholar
  7. 7.
    McNamara PJ, Laique F, Muang-In S, Whyte HE (2006) Milrinone improves oxygenation in neonates with severe persistent pulmonary hypertension of the newborn. J Crit Care 21(2):217–222.  https://doi.org/10.1016/j.jcrc.2006.01.001 CrossRefPubMedGoogle Scholar
  8. 8.
    Patel N (2012) Use of milrinone to treat cardiac dysfunction in infants with pulmonary hypertension secondary to congenital diaphragmatic hernia: a review of six patients. Neonatology 102(2):130–136.  https://doi.org/10.1159/000339108 CrossRefPubMedGoogle Scholar
  9. 9.
    Lakshminrusimha S, Keszler M, Kirpalani H, Van Meurs K, Chess P, Ambalavanan N, Yoder B, Fraga MV, Hedrick H, Lally KP, Nelin L, Cotten M, Klein J, Guilford S, Williams A, Chaudhary A, Gantz M, Gabrio J, Chowdhury D, Zaterka-Baxter K, Das A, Higgins RD (2017) Milrinone in congenital diaphragmatic hernia—a randomized pilot trial: study protocol, review of literature and survey of current practices. Matern Health Neonatol Perinatol 3:27.  https://doi.org/10.1186/s40748-017-0066-9 CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Neonatal Inhaled Nitric Oxide Study G (1997) Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 336 (9):597–604.  https://doi.org/10.1056/NEJM199702273360901 CrossRefGoogle Scholar
  11. 11.
    Aly H, Bianco-Batlles D, Mohamed MA, Hammad TA (2010) Mortality in infants with congenital diaphragmatic hernia: a study of the United States National Database. J Perinatol 30(8):553–557.  https://doi.org/10.1038/jp.2009.194 CrossRefPubMedGoogle Scholar
  12. 12.
    Kumar VH (2015) Current concepts in the management of congenital diaphragmatic hernia in infants. Indian J Surg 77(4):313–321.  https://doi.org/10.1007/s12262-015-1286-8 CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Reiss I, Schaible T, van den Hout L, Capolupo I, Allegaert K, van Heijst A, Gorett Silva M, Greenough A, Tibboel D, Consortium CE (2010) Standardized postnatal management of infants with congenital diaphragmatic hernia in Europe: the CDH EURO consortium consensus. Neonatology 98(4):354–364.  https://doi.org/10.1159/000320622 CrossRefPubMedGoogle Scholar
  14. 14.
    Patel N, Kipfmueller F (2017) Cardiac dysfunction in congenital diaphragmatic hernia: Pathophysiology, clinical assessment, and management. Semin Pediatr Surg 26(3):154–158.  https://doi.org/10.1053/j.sempedsurg.2017.04.001 CrossRefPubMedGoogle Scholar
  15. 15.
    Konduri GG, Sokol GM, Van Meurs KP, Singer J, Ambalavanan N, Lee T, Solimano A (2013) Impact of early surfactant and inhaled nitric oxide therapies on outcomes in term/late preterm neonates with moderate hypoxic respiratory failure. J Perinatol 33(12):944–949.  https://doi.org/10.1038/jp.2013.83 CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Lakshminrusimha S (2012) The pulmonary circulation in neonatal respiratory failure. Clin Perinatol 39(3):655–683.  https://doi.org/10.1016/j.clp.2012.06.006 CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Bassler D, Kreutzer K, McNamara P, Kirpalani H (2010) Milrinone for persistent pulmonary hypertension of the newborn. Cochrane Database Syst Rev (11):CD007802.  https://doi.org/10.1002/14651858.CD007802.pub2
  18. 18.
    James AT, Bee C, Corcoran JD, McNamara PJ, Franklin O, El-Khuffash AF (2015) Treatment of premature infants with pulmonary hypertension and right ventricular dysfunction with milrinone: a case series. J Perinatol 35(4):268–273.  https://doi.org/10.1038/jp.2014.208 CrossRefPubMedGoogle Scholar
  19. 19.
    James AT, Corcoran JD, McNamara PJ, Franklin O, El-Khuffash AF (2016) The effect of milrinone on right and left ventricular function when used as a rescue therapy for term infants with pulmonary hypertension. Cardiol Young 26(1):90–99.  https://doi.org/10.1017/S1047951114002698 CrossRefPubMedGoogle Scholar
  20. 20.
    Putnam LR, Harting MT, Tsao K, Morini F, Yoder BA, Luco M, Lally PA, Lally KP, Congenital Diaphragmatic Hernia Study G (2016) Congenital diaphragmatic hernia defect size and infant morbidity at discharge. Pediatrics.  https://doi.org/10.1542/peds.2016-2043 PubMedGoogle Scholar
  21. 21.
    Paden ML, Conrad SA, Rycus PT, Thiagarajan RR, Registry E (2013) Extracorporeal life support organization registry report 2012. ASAIO J 59(3):202–210.  https://doi.org/10.1097/MAT.0b013e3182904a52 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Vasantha H. S. Kumar
    • 1
    • 4
  • Rita Dadiz
    • 2
  • Jamie Koumoundouros
    • 1
  • Stephanie Guilford
    • 1
  • Satyan Lakshminrusimha
    • 3
  1. 1.Department of PediatricsUniversity at BuffaloBuffaloUSA
  2. 2.University of Rochester Medical CenterRochesterUSA
  3. 3.Department of PediatricsUniversity of California Davis Children’s HospitalSacramentoUSA
  4. 4.Division of Neonatology, Department of Pediatrics, John R Oishei Children’s HospitalUniversity at BuffaloBuffaloUSA

Personalised recommendations